Scientists have discovered new chronic kidney disease treatment options in 2025-2026, from finerenone for non-diabetic CKD to ...

Medicare Fails to Keep Up with Kidney Disease Treatment Advances ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

Chronic kidney disease (CKD) affects 10% of the global population. Medication dosing errors in people with impaired kidney ...

The National Kidney Foundation (NKF) recently announced the launch of the Implementing Medication Decisions with eGFR (IMeD-eGFR) Community, a national collaborative designed to help healthcare ...

One in ten adults suffer from chronic kidney disease (CKD), a condition characterized by progressive loss of kidney function. Altered kidney function can impact the risk/benefit of many medications.

Approximately 35 million adults in the United States suffer from chronic kidney disease (CKD), and that number is growing. Meanwhile, there's a critical shortage of nephrologists to manage these ...

ST. PAUL, Minn., Nov. 6 (UPI) --Positive results from a late-stage clinical trial released Thursday have raised hopes that type 1 diabetes patients who suffer from chronic kidney disease will have a ...

New research shows people with type 2 diabetes and chronic kidney disease who took semaglutide (commonly sold as Ozempic) once a week had improved kidney outcomes, even if they had heart disease or a ...

Polycystic Kidney Disease often progresses silently for years. Doctors explain early symptoms, genetic risks, diagnosis, ...

Chronic kidney disease often progresses without obvious symptoms until significant damage has already occurred. Doctors ...

Despite treatment advances, kidney disease burden remained unchanged over the past decade ...